Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMBINATION DRUG SUITABLE FOR TREATMENT AND PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLAD) AND/OR NON-ALCOHOLIC STEATOHEPATITIS (NASH), AND/OR HEPATIC STEATOSIS
Document Type and Number:
WIPO Patent Application WO/2019/106851
Kind Code:
A1
Abstract:
[Problem] To provide a pharmaceutical product and health food that are suitable for treatment and prevention of hepatitis virus-unrelated non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic steatosis. [Solution] This combination drug contains a zinc preparation and a selenium preparation as active ingredients, and is suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic steatosis.

Inventors:
KUBOTA, Satoru (A2-412, 1-22 Yamadanishi, Suita-sh, Osaka 24, 〒5650824, JP)
KONO, Toru (1-6-22, 2-jo Toyooka, Asahikawa-sh, Hokkaido 32, 〒0788232, JP)
Application Number:
JP2017/043898
Publication Date:
June 06, 2019
Filing Date:
November 30, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDICO CONSL CO., LTD. (A2-412, 1-22 Yamadanishi, Suita-sh, Osaka 24, 〒5650824, JP)
International Classes:
A61K33/30; A23L33/16; A61K33/04; A61P1/16
Attorney, Agent or Firm:
MIYAZAKI, Tadaaki et al. (MIYAZAKI INTERNATIONAL PATENT ATTORNEYS, Live Building 203 30-13, Tarumi-cho 3-chome, Suita-sh, Osaka 62, 〒5640062, JP)
Download PDF: